Skip to main content

Concepció Jacobs Cachá

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Concepció Jacobs Cachá

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Projects

Caracterización molecular de Apolipoproteína A-Ib (ApoA-Ib): resolviendo el enigma del síndrome nefrótico idiopático.

IP: Concepció Jacobs Cachá
Collaborators: -
Funding agency: Fundación Renal Iñigo Alvarez de Toledo
Funding: 6000
Reference: FRIAT/PREMIS/2020/JACOBS
Duration: 22/09/2020 - 22/09/2020

Deciphering the Mechanisms of PLA2R-specific B-cell Autoimmunity in Primary Membranous Nephropathy (PMN)(BCELL-MEM)

IP: Maria Jose Soler Romeo
Collaborators: Laura Donadeu Casassas, Oriol Bestard Matamoros, Elena Isabel Crespo Gimeno, Concepció Jacobs Cachá
Funding agency: Fundació La Marató de TV3
Funding: 199935.54
Reference: 202037-31
Duration: 01/06/2021 - 31/12/2024

Role of Apolipoprotein A-Ib in the idiopathic nephrotic syndrome

IP: Concepció Jacobs Cachá
Collaborators: -
Funding agency: Fundació La Marató de TV3
Funding: 199966.31
Reference: 202017/10
Duration: 30/03/2021 - 31/12/2024

Modelo predictivo del riesgo de infección y rechazo después del trasplante renal basado en la combinadición de parámetros clínicos y biomarcadores.

IP: Francesc Moreso Mateos
Collaborators: Joana Sellarés Roig, Concepció Jacobs Cachá, Manel Perelló Carrascosa, Romina Dieli Crimi, Nestor Gabriel Toapanta Gaibor, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI18/01832
Duration: 01/01/2019 - 31/12/2022

Related news

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Related professionals

Marc Ribó Jacobi

Marc Ribó Jacobi

Main researcher
Stroke research
Read more
Raquel Maria Lastra Borras

Raquel Maria Lastra Borras

Research technician
Headache and Neurological Pain
Read more
Lara Grau Lopez

Lara Grau Lopez

Psychiatry, Mental Health and Addictions
Read more
Iris Garcia Martínez

Iris Garcia Martínez

Postdoctoral researcher
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.